Previous close | 6.25 |
Open | 5.99 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 5.99 - 5.99 |
52-week range | 5.99 - 5.99 |
Volume | |
Avg. volume | N/A |
Market cap | 797,979 |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NANTES, France, January 03, 2023--OSE Immunotherapeutics Announces Upcoming Investor Meetings in Q1 2023.
NANTES, France, December 22, 2022--OSE Immuno Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas
NANTES, France, December 16, 2022--OSE Immunotherapeutics Receives a €10 Million Payment Corresponding to the Second Tranche of the Financing Granted by the European Investment Bank